Huma CVD:

The leading digital platform for cardiovascular risk prediction and prevention

Built to reach large, at-risk populations with a low-burden digital screening pathway.

Built to reach large, at-risk populations with a low-burden digital screening pathway.

Early CVD risk detection and prevention.

Early CVD risk detection and prevention.

Early CVD risk detection and prevention.

Enhanced patient education and engagement.

Enhanced patient education and engagement.

Enhanced patient education and engagement.

Actionable clinical insights for better care.

Actionable clinical insights for better care.

Actionable clinical insights for better care.

Improved outcomes through timely intervention.

Improved outcomes through timely intervention.

Improved outcomes through timely intervention.

Cardiovascular disease is preventable when detected early - Huma CVD helps clinicians and patients take action sooner.

Cardiovascular disease develops over years and is driven by lifestyle, metabolic and clinical factors. Many people remain unaware of elevated risk until a major event occurs. Huma CVD combines a brief, clinically-designed digital assessment with optional device inputs and clinician workflows to predict 10-year cardiovascular risk, guide personalised prevention and close the gap between risk detection and clinical action.

Cardiovascular disease is preventable when detected early - Huma CVD helps clinicians and patients take action sooner.

Cardiovascular disease develops over years and is driven by lifestyle, metabolic and clinical factors. Many people remain unaware of elevated risk until a major event occurs. Huma CVD combines a brief, clinically-designed digital assessment with optional device inputs and clinician workflows to predict 10-year cardiovascular risk, guide personalised prevention and close the gap between risk detection and clinical action.

Huma CVD is deployed globally across health systems and partnerships, including the Bayer Heart Risk Assessment program.

Huma CVD is deployed globally across health systems and partnerships, including the Bayer Heart Risk Assessment program.

Huma CVD is deployed globally across health systems and partnerships, including the Bayer Heart Risk Assessment program.

Built on Huma’s regulated SaMD platform (FDA Class II clearance for Huma’s SaMD platform), with governance and data controls for clinical use.

How Huma CVD identifies risk and supports prevention

How Huma CVD identifies risk and supports prevention

Patient-facing assessment

Patient-facing assessment

Individuals complete a short, evidence-based digital questionnaire (medical history, lifestyle, symptoms, medications) via the Huma app. Optional camera measurements and wearable integrations enrich the assessment where available.

Individuals complete a short, evidence-based digital questionnaire (medical history, lifestyle, symptoms, medications) via the Huma app. Optional camera measurements and wearable integrations enrich the assessment where available.

Risk modelling & interpretation

Risk modelling & interpretation

A validated algorithm processes inputs to generate a personalised 10-year CVD risk estimate and a contributor-level breakdown so clinicians and users understand key drivers of risk.

A validated algorithm processes inputs to generate a personalised 10-year CVD risk estimate and a contributor-level breakdown so clinicians and users understand key drivers of risk.

Clinician workflows & action

Clinician workflows & action

Results appear in a secure clinician dashboard with configurable triage thresholds, referral prompts and follow-up tasks - enabling rapid, evidence-based prevention (lifestyle support, diagnostics, medication review).

Results appear in a secure clinician dashboard with configurable triage thresholds, referral prompts and follow-up tasks - enabling rapid, evidence-based prevention (lifestyle support, diagnostics, medication review).

Data & clinical foundations

Data & clinical foundations

15+ Years

of validated

CVD data

500K+

Participants powering heart risk models

3+

Global studies validating outcomes

Advanced models and accessible measurements

Advanced models and accessible measurements

Advanced models and accessible measurements

Evidence-based risk engine

Validated predictive models estimate 10-year risk using self-reported inputs and optional physiological data.

Camera and sensor inputs

Phone camera measurements (heart-rate capture) and wearable data can be incorporated to improve longitudinal monitoring.

No specialised hardware required

The primary pathway works via smartphone questionnaire, widening access for community and population screening.

Scaling prevention through partnerships

Huma CVD combines pharma, public health and academic partnerships to increase screening reach and support population-level prevention strategies. Partnered launches and campaigns (including Bayer programmes and regional rollouts) demonstrate practical, scalable deployment models for healthcare systems and public health initiatives.

Scaling prevention through partnerships

Huma CVD combines pharma, public health and academic partnerships to increase screening reach and support population-level prevention strategies. Partnered launches and campaigns (including Bayer programmes and regional rollouts) demonstrate practical, scalable deployment models for healthcare systems and public health initiatives.

Take the next step

Tell us what you’re solving for and a Huma expert will help you find the best solution.